You are here

Company Monitoring Page for Incyte

latest headlines for company on cafepharma

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts

Yahoo/Benzinga

Sun, 06/9/19 - 01:36 pm

#ASCO19: MET inhibitors from Incyte/Novartis and Germany's Merck face off for rare subset of NSCLC patients

Endpoints

Tue, 06/4/19 - 12:16 pm

Tags:

Novartis, ASCO 2019, Incyte, MET inhibitors, capmatinib, non-small cell lung cancer

Incyte (INCY) Receives FDA Nod for Label Expansion of Jakafi

Yahoo/Zacks.com

Tue, 05/28/19 - 10:07 am

Tags:

FDA, Incyte, Jakafi, graft vs host disease

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Yahoo/Benzinga

Sun, 05/19/19 - 03:59 pm

Tags:

Incyte, Novartis, Athersys, ResTORbio, Bellerophon Therapeutics, Eli Lilly, CymaBay, Bicycle Therapeutics, Peloton Therapeutics, Ideaya, IPOs

Biotech Companies Provide High Median Salaries, Analysis Shows

BioSpace

Thu, 05/9/19 - 11:07 pm

Tags:

salaries, biotech, Incyte, Celgene, Vertex Pharmaceuticals

Incyte pulls away 'damaged goods' baricitinib to focus on internal pipeline

Endpoints

Tue, 04/30/19 - 08:57 pm

Tags:

Incyte, olumiant, baricitinib, FDA, Eli Lilly

Incyte Down as FDA Extends Review Period of Jakafi for GVHD

Yahoo/Zacks.com

Sat, 02/9/19 - 12:23 pm

Tags:

Incyte, FDA, Jakafi, graft vs host disease

Lilly and Incyte's Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials

BioSpace

Mon, 02/4/19 - 11:49 am

Tags:

Eli Lilly, Incyte, olumiant, atopic dermatitis, clinical trials

Mark Your Calendar For These February PDUFA Dates

Yahoo/Benzinga

Sat, 02/2/19 - 12:31 pm

Tags:

FDA, DWP-450, Evolus, MOTIF BIO PLC/S ADR, Iclaprim, Bausch Health, Duobrii, Merck, Keytruda, Incyte, Novartis, ruxolitinib, Novo Nordisk, N8-GP

Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter

Investors Business Daily

Wed, 01/16/19 - 11:55 am

Tags:

Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018

BioSpace

Fri, 12/21/18 - 12:10 pm

Innovent, Incyte sign collaboration deal for three clinical-stage product candidates

Pharmaceutical Business Review

Mon, 12/17/18 - 09:02 am

Tags:

Incyte, Innovent Biologics, pemigatinib, itacitinib, parsaclisib

5 Top Drug/Biotech Merger & Acquisition Targets for 2019

Yahoo/Zacks.com

Mon, 12/10/18 - 09:50 am

Tags:

M&A, Biomarin, Vertex Pharmaceuticals, Incyte, Alnylam, Alexion

FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease

CP Wire

Thu, 10/25/18 - 09:52 am

Tags:

FDA, Incyte, Novartis, Jakavi, Jakafi, graft vs host disease

Thu, 10/25/18 - 09:33 am

Tags:

Incyte, graft vs host disease, Novartis, Jakafi

Agenus sells cut of Incyte, Merck milestone streams

Fierce Biotech

Fri, 09/21/18 - 09:55 am

Tags:

Agenus, Incyte, Merck, Xoma

Incyte preps Jakafi expansion into graft-versus-host disease

Biopharma Dive

Thu, 06/21/18 - 11:00 pm

Tags:

Incyte, Jakafi, graft vs host disease

Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning

Xconomy

Fri, 06/1/18 - 10:36 pm

Tags:

Eli Lilly, Incyte, FDA, rheumatoid arthritis, olumiant, baricitinib

3 Biotechs With Huge FDA Decisions in June

Motley Fool

Thu, 05/31/18 - 10:00 pm

Tags:

biotech, Array Biopharma, encorafenib, binimetinib, GW Pharma, Epidiolex, Incyte, olumiant

IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down

Xconomy

Thu, 05/31/18 - 08:17 pm

Tags:

ASCO, oncology, IDO inhibitors, Incyte

Pages

last 30 twitter posts